Vir Biotechnology’s Chief Accounting Officer, Brent Sabatini, sold 1,562 shares at $9.15 each, reducing his stake by 5.25% to 28,189 shares. Despite the share sale,
Tag: Market Analysis
Big Moves at MAIA Biotechnology! Insider Buying and Market Insights
Significant Share Purchase Revealed In a noteworthy development on December 13th, Stan Smith, a director at MAIA Biotechnology, Inc., made a substantial investment by acquiring